secwatch.observer — SEC 8-K summary
======================================

Issuer:     DELCATH SYSTEMS, INC. (DCTH)
CIK:        0000872912
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-010498
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Delcath prelim FY2025 revenue $85.2M, HEPZATO $78.8M, cash $91M
---------------------------------------------------------------

- Total Q4 revenue ~$20.7M, FY revenue ~$85.2M; HEPZATO KIT Q4 ~$19.0M, FY ~$78.8M.
- CHEMOSAT Q4 revenue ~$1.7M, FY ~$6.4M.
- Cash and short-term investments ~$91.0M as of Dec 31, 2025; no debt.
- 628,572 shares repurchased for $6.0M under $25M buyback program.
- 25 active sites; ~140% growth in HEPZATO procedure volume YoY; positive operating cash flow in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872912/000119312526010498/0001193125-26-010498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872912/000119312526010498/d52022d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-010498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer